# Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?

Study · id `cardio:ct-nct03368066` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03368066](<https://clinicaltrials.gov/study/NCT03368066>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03368066

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03368066. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-01-29 (actual); primary completion 2019-03-12 (actual). Results posted on 2021-12-09.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03368066, source copy `cardio:ctgov-nct03368066-2021-12-09`, retrieved 2026-10-31)
- Started: 2018-01-29 (actual) (ClinicalTrials.gov record NCT03368066, source copy `cardio:ctgov-nct03368066-2021-12-09`, retrieved 2026-10-31)
- Primary completion: 2019-03-12 (actual) (ClinicalTrials.gov record NCT03368066, source copy `cardio:ctgov-nct03368066-2021-12-09`, retrieved 2026-10-31)
- Completion: 2019-03-12 (actual) (ClinicalTrials.gov record NCT03368066, source copy `cardio:ctgov-nct03368066-2021-12-09`, retrieved 2026-10-31)
- Results first posted: 2021-12-09 (ClinicalTrials.gov record NCT03368066, source copy `cardio:ctgov-nct03368066-2021-12-09`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT03368066, source copy `cardio:ctgov-nct03368066-2021-12-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03368066-2021-12-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
- Condition: Adrenal Insufficiency
- Condition: Cirrhosis
- Condition: Spur Cell Anemia
- Condition: Lecithin Acyltransferase Deficiency
- Intervention (Drug): Cosyntropin
- Lead sponsor: University of Virginia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: University of Virginia (`cardio:org-university-of-virginia`)

## Provenance

Content hash: c4fda0744b3642a327a335f96e5376cda940e7269e0b20d7a220d8586c74c4b6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
